Last Rytvela’s article featured!

The article: Antenatal suppression of interleukin-1 protects against inflammation-induced fetal injury and improves neonatal and developmental outcomes in mice published recently in the Journal of Immunology was featured in their “In This Issue” section which highlights articles considered to be among the top 10% of articles published in the journal.

“We are very proud of this recognition,” says Jean-Paul Castaigne, MD, MBA, co-founder and CEO of Rytvel Biotech. “To be featured in the “In This Issue” section of such a prestigious publication demonstrates the solidity of the data presented and the seriousness and credibility of the three research teams who participated independently to generate them in a blinded way”.